A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacy
about
Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases.The meteorology of cytokine storms, and the clinical usefulness of this knowledgeCytokine-modulating strategies and newer cytokine targets for arthritis therapy.Gene therapy with the caspase activation and recruitment domain reduces the ocular inflammatory responseValue of Functionalized Superparamagnetic Iron Oxide Nanoparticles in the Diagnosis and Treatment of Acute Temporal Lobe Epilepsy on MRI.C5a Regulates IL-1β Production and Leukocyte Recruitment in a Murine Model of Monosodium Urate Crystal-Induced Peritonitis.IL-1β and IL-6 Are Highly Expressed in RF+IgE+ Systemic Lupus Erythematous SubtypeNew treatments for inflammatory rheumatic disease.Necroinflammation in Kidney Disease.Pharmacological treatment options for cryopyrin-associated periodic syndromes.Old and new therapeutics for Rheumatoid Arthritis: in vivo models and drug development.Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma.Imaging PD-L1 Expression with ImmunoPET.Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection
P2860
Q33710807-678AF65B-5C86-4528-8372-71E39C6CDE4AQ33867213-4BB7A041-295D-4BD4-AEBE-00ECFF7C3A3BQ34456715-D982270C-EE23-4BCB-B198-D3B50433BE97Q35594870-D4BFA58E-77BB-4ACD-B2A9-CC8577F7FEEBQ36564626-562A1FF7-AA1C-42B8-A823-823D9454E13FQ37597916-53142895-B1F8-449C-8CA9-E45F4F9CC688Q37670861-6A2EC93E-7D27-47DC-971C-0BD6FB2C3C6FQ38266252-7866E62A-039C-44AD-B4E6-D9B1A5EEF97BQ38579499-50148D1B-40B6-435B-8589-FECEE38CAC95Q38674213-287DEF84-B93C-401D-81F6-4478EECD9181Q38697262-9473FA60-8C21-4172-BC75-A62E27132C63Q45756098-6BE76DD1-19CE-4701-91EE-4CE9FEC259F1Q48324917-FE5D4537-18EC-4734-9401-A01EE9330C74Q56558172-B9C5E654-B2BB-4FE3-9595-1135555CA31B
P2860
A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacy
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A novel human anti-interleukin ...... ibody showing in vivo efficacy
@ast
A novel human anti-interleukin ...... ibody showing in vivo efficacy
@en
A novel human anti-interleukin ...... body showing in vivo efficacy.
@nl
type
label
A novel human anti-interleukin ...... ibody showing in vivo efficacy
@ast
A novel human anti-interleukin ...... ibody showing in vivo efficacy
@en
A novel human anti-interleukin ...... body showing in vivo efficacy.
@nl
prefLabel
A novel human anti-interleukin ...... ibody showing in vivo efficacy
@ast
A novel human anti-interleukin ...... ibody showing in vivo efficacy
@en
A novel human anti-interleukin ...... body showing in vivo efficacy.
@nl
P2093
P2860
P356
P1476
A novel human anti-interleukin ...... ibody showing in vivo efficacy
@en
P2093
Adrian W S Ho
Angeline X H Goh
Cheng-I Wang
Heidi Derks
Sebastien Bertin-Maghit
Siok Ping Yeo
P2860
P304
P356
10.4161/MABS.28614
P577
2014-03-26T00:00:00Z